Stay updated on HIV+ Safety of High-dose Rifapentine-Isoniazid DDI Clinical Trial
Sign up to get notified when there's something new on the HIV+ Safety of High-dose Rifapentine-Isoniazid DDI Clinical Trial page.

Latest updates to the HIV+ Safety of High-dose Rifapentine-Isoniazid DDI Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedPublication notes now indicate that items are automatically filled from PubMed and may not be about the study. A revision tag for v3.3.2 was added, and the prior PubMed-origin wording and v3.2.0 revision note were removed.SummaryDifference0.1%

- Check28 days agoChange DetectedRemoved the government funding lapse notice from the page; the study details and navigation remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check42 days agoChange DetectedNo additions or deletions were detected for the page; the content and layout appear unchanged in the provided screenshots.SummaryDifference0.5%

- Check71 days agoChange DetectedCore content updated with a funding-status notice and a new version number (v3.2.0); previous v3.1.0 was removed. If no other substantive changes, this primarily communicates operational status and a software version bump.SummaryDifference2%

- Check78 days agoChange DetectedUpdated the page revision from v3.0.2 to v3.1.0, indicating a new software release or update a v3.1.0 release tag.SummaryDifference0.1%

- Check93 days agoChange DetectedRevision updated from v3.0.1 to v3.0.2. The Back to Top element was removed.SummaryDifference0.1%

Stay in the know with updates to HIV+ Safety of High-dose Rifapentine-Isoniazid DDI Clinical Trial
Enter your email address, and we'll notify you when there's something new on the HIV+ Safety of High-dose Rifapentine-Isoniazid DDI Clinical Trial page.